Adiv Johnson at ARDD2026: Buccal methylomic data to generate novel insights into epigenetic aging

Adiv Johnson, Tally Health, presents at the 13th Aging Research and Drug Discovery Meeting: Using buccal methylomic data to generate novel insights into epigenetic aging Key takeaway: Epigenetic clocks become more reliable and useful by suppressing technical noise and explaining age predictions through modifiable biomarker proxies. The Aging Research and Drug Discovery (ARDD) meeting is the world's leading conference dedicated to longevity biotechnology. It convenes top researchers, pharmaceutical executives, regulators, entrepreneurs, and investors to accelerate the translation of aging science into next-generation medicines. ARDD was founded by Alex Zhavoronkov in 2014. Following years of growth in Europe, ARDD made its North American debut in Boston at the David Rubenstein Treehouse at Harvard University on October 1-3, 2026. The conference opened with a ribbon-cutting ceremony led by Admiral Brian Christine, US Assistant Secretary for Health, to commemorate its move to the US. Follow us for updates on ARDD 2027 in Boston! Website: https://agingpharma.org/ LinkedIn: https://www.linkedin.com/company/agingpharma/ ARDD 2026 was organized by @InsilicoMedicine with support from Eli Lilly, AstraZeneca, AbbVie, Novo Nordisk, Nestlé, XPRIZE Healthspan, Human Longevity, Dior, Maxwell Biosciences, Microsoft, BioAge, Gordian Biotechnology, GlycanAge, LongeVC, AniVC, Tolerance Bio, Tally Health, Institute for Healthier Living Abu Dhabi, TruDiagnostic, Cambrian Bio, ARTAN Bio, bio.xyz, Cyclarity Therapeutics, Rubedo Life Sciences, Biocytogen, SAISHO, Life Biosciences, Shift Bioscience, Synaro Capital, Biointron, The Cat Health Company, PranaGen Bioscience, Rhizome, Einstein BIO-VITAL Program, Alden Scientific, BDO, Cole-Frieman & Mallon, Morgan Stanley, Estée Lauder Companies, ICFSR, QuadraScope, BrainKey, Retro Biosciences, Compound Life, MobiDrop, Trilliome, and Nagi Bioscience. #ARDD2026 #longevity #aging #drugdiscovery